AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Bonacini, M Lin, HJ Hollinger, FB
Citation: M. Bonacini et al., Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus, J ACQ IMM D, 26(4), 2001, pp. 340-344

Authors: Lin, HJ Seeff, LB Barbosa, L Hollinger, FB
Citation: Hj. Lin et al., Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: Divergenceover time, HEPATOLOGY, 34(2), 2001, pp. 424-429

Authors: Seeff, LB Hollinger, FB Alter, HJ Wright, EC Cain, CMB Buskell, ZJ Ishak, KG Iber, FL Toro, D Samanta, A Koretz, RL Perrillo, RP Goodman, ZD Knodell, RG Gitnick, G Morgan, TR Schiff, ER Lasky, S Stevens, C Vlahcevic, RZ Weinshel, E Tanwandee, T Lin, HJ Barbosa, L
Citation: Lb. Seeff et al., Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A national heart, lung, and blood institute collaborative study, HEPATOLOGY, 33(2), 2001, pp. 455-463

Authors: Lin, HJ Siwak, EB Lander, IJ Hollinger, FB
Citation: Hj. Lin et al., Long-term culture of human immunodeficiency virus type 1 resulting in lossof glycosylation sites, J MED VIROL, 63(3), 2001, pp. 197-202

Authors: Harris, DR Gonin, R Alter, HJ Wright, EC Buskell, ZJ Hollinger, FB Seeff, LB
Citation: Dr. Harris et al., The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse, ANN INT MED, 134(2), 2001, pp. 120-124

Authors: Keeffe, EB Dusheiko, GM Tong, MJ Hollinger, FB Heathcote, EJL McHutchison, J Albert, D
Citation: Eb. Keeffe et al., Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C, CYTOK CELL, 5(4), 1999, pp. 211-216

Authors: Pockros, PJ Bain, VG Hunter, EB Conrad, A Balart, A Hollinger, FB Albert, D
Citation: Pj. Pockros et al., A comparison of reverse transcription polymerase chain reaction and branched-chain DNA assays for hepatitis C virus RNA in patients receiving interferon treatment, J VIRAL HEP, 6(2), 1999, pp. 145-150

Authors: Lavanchy, D Purcell, R Hollinger, FB Howard, C Alberti, A Kew, M Dusheiko, G Alter, M Ayoola, E Beutels, P Bloomer, R Ferret, B Decker, R Esteban, R Fay, O Fields, H Fuller, EC Grob, P Houghton, M Leung, N Locarnini, SA Margolis, H Meheus, A Miyamura, T Mohamed, MK Tandon, B Thomas, D Head, HT Toukan, AU Van Damme, P Zanetti, A Arthur, R Couper, M D'Amelio, R Emmanuel, JC Esteves, K Gavinio, P Griffiths, E Hallaj, Z Heuck, CC Heymann, DL Holck, SE Kane, M Martinez, LJ Meslin, F Mochny, IS Ndikuyeze, A Padilla, AM Rodier, GRM Roure, C Savage, F Vercauteren, G
Citation: D. Lavanchy et al., Global surveillance and control of hepatitis C, J VIRAL HEP, 6(1), 1999, pp. 35-47

Authors: Jensen, DM Krawitt, EL Keeffe, EB Hollinger, FB James, SP Mullen, K Everson, GT Hoefs, JC Fromm, H Black, M Foust, RT Pimstone, PR Heathcote, EJL Albert, D
Citation: Dm. Jensen et al., Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: Effect of baseline viral concentration, AM J GASTRO, 94(12), 1999, pp. 3583-3588
Risultati: 1-9 |